Australia markets closed

4D Molecular Therapeutics, Inc. (FDMT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
23.53-0.72 (-2.97%)
At close: 04:00PM EDT
23.81 +0.28 (+1.19%)
Pre-market: 08:05AM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts6677
Avg. Estimate-0.74-0.75-3.06-3.4
Low estimate-0.84-0.85-3.29-4.5
High estimate-0.68-0.7-2.89-1.31
Year ago EPS-0.88-0.77-2.58-3.06
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts6675
Avg. Estimate780k760k5.76M7.46M
Low estimateN/AN/AN/AN/A
High estimate3.3M3.3M21M16.9M
Year ago sales298k850k20.72M5.76M
Sales growth (year/est)161.70%-10.60%-72.20%29.50%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.89-0.81-0.59-0.74
Actual EPS-0.88-0.77-0.24-0.75
Difference0.010.040.35-0.01
Surprise %1.10%4.90%59.30%-1.40%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.74-0.75-3.06-3.4
7 days ago-0.74-0.75-3.06-3.4
30 days ago-0.72-0.73-3.03-3.82
60 days ago-0.76-0.7-3-3.32
90 days ago-0.83-0.75-3.1-3.49
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/A11
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesFDMTIndustrySector(s)S&P 500
Current qtr.15.90%N/AN/AN/A
Next qtr.2.60%N/AN/AN/A
Current year-18.60%N/AN/AN/A
Next year-11.10%N/AN/AN/A
Next 5 years (per annum)-15.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A